SR
Sachin Rameshrao Chavan
About Sachin Rameshrao Chavan
Data last updated:
Sachin Rameshrao Chavan has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Astrella Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Astrella Pharmaceutical Private Limited at ₹3.41 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Astrella Pharmaceutical Private Limited U51909PN2018PTC180384 | Director | 27 Nov 2018 | 2018 | ₹3.41 Cr (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sachin Rameshrao Chavan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sachin Rameshrao Chavan
Sachin Rameshrao Chavan has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Astrella Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Astrella Pharmaceutical Private Limited at ₹3.41 Cr (FY 2024).
Sachin Rameshrao Chavan is associated with 1 company as Director, including Astrella Pharmaceutical Private Limited (₹3.41 Cr).
Sachin Rameshrao Chavan has expertise in General Business.
Sachin Rameshrao Chavan has 7 years in corporate governance.
By reported revenue, the largest current company of Sachin Rameshrao Chavan is Astrella Pharmaceutical Private Limited, with revenue of ₹3.41 Cr (FY 2024).
Sachin Rameshrao Chavan currently holds positions at 1 company: Astrella Pharmaceutical Private Limited (₹3.41 Cr).